Inflammatory Markers as Prognostic Factors of Survival in Patients Affected by Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization

Inflammatory Markers as Prognostic Factors of Survival in Patients Affected by Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization

Introduction. Transarterial chemoembolization (TACE) is a good choice for hepatocellular carcinoma (HCC) treatment when surgery and liver transplantation are not feasible. Few studies reported the value of prognostic factors influencing survival after chemoembolization. In this study, we evaluated w...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. Rebonato, L. Graziosi, D. Maiettini, E. Marino, V. De Angelis, L. Brunese, S. Mosca, G. Metro, M. Rossi, G. Orgera, M. Scialpi, A. Donini
Format:	Article
Language:	English
Published:	Wiley 2017-01-01
Series:	Gastroenterology Research and Practice
Online Access:	http://dx.doi.org/10.1155/2017/4164130
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

TRACE Model: Predicting Treatment Response to Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma
by: Wang W, et al.
Published: (2025-01-01)

A Lethal Complication after Transarterial Chemoembolization with Drug-Eluting Beads for Hepatocellular Carcinoma
by: Adriana Toro, et al.
Published: (2015-01-01)

Hepatocellular Carcinoma in Liver Cirrhosis: Surgical Resection versus Transarterial Chemoembolization—A Meta-Analysis
by: Teodor Kapitanov, et al.
Published: (2015-01-01)

Transarterial Chemoembolization of Metastatic Liver Lesions in Patients with Colorectal Cancer
by: O. Yu. Stukalova, et al.
Published: (2019-12-01)

Early release of circulating tumor cells after transarterial chemoembolization hinders therapeutic response in patients with hepatocellular carcinoma
by: María L. Espejo-Cruz, et al.
Published: (2025-01-01)

Clinical Outcomes of Drug-Eluting Bead Transarterial Chemoembolization Loaded with Raltitrexed for the Treatment of Unresectable or Recurrent Hepatocellular Carcinoma
by: Yonghua Bi, et al.
Published: (2022-01-01)

Case report: Transarterial chemoembolization for nasal hemangiosarcoma in a dog
by: Keunho Kim, et al.
Published: (2025-01-01)

Association between transarterial chemoembolization refractoriness and prognosis in Chinese patients with hepatocellular carcinoma: a large retrospective cohort study
by: Qinxue Sun, et al.
Published: (2025-01-01)

Gastrointestinal side effects in hepatocellular carcinoma patients receiving transarterial chemoembolization: a meta-analysis of 81 studies and 9495 patients
by: Nathalie Arendt, et al.
Published: (2025-02-01)

Survival and Its Predictors Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma in Ethiopia: A 6-Year Follow-Up Study
by: Abigia Ashenafi, et al.
Published: (2025-01-01)

A Lipiodol Pickering Emulsion Stabilized by Iron‐Doped Carbon Nanozymes for Liver Transarterial Chemoembolization
by: Xiancheng Xia, et al.
Published: (2025-02-01)

Efficacy and Safety of the Combination of Transarterial Chemoembolization with Camrelizumab plus Apatinib for Advanced Hepatocellular Carcinoma: A Retrospective Study of 38 Patients from a Single Center
by: Jin-Xing Zhang, et al.
Published: (2022-01-01)

Conventional and drug‑eluting bead transarterial chemoembolization in patients with inoperable intrahepatic cholangiocarcinoma: a meta‑analysis
by: Su-Rong Pan, et al.
Published: (2024-11-01)

New Method of Parent Catheter Advancement in the Balloon Anchor Technique during Balloon-Occluded Transarterial Chemoembolization for Hepatic Tumors
by: Kei Shibuya, et al.
Published: (2016-01-01)

Transcatheter Arterial Chemoembolization Based on Hepatic Hemodynamics for Hepatocellular Carcinoma
by: Satoru Murata, et al.
Published: (2013-01-01)

Antibiotic Prophylaxis in Transarterial Therapy of Hepatocellular Carcinoma: A Meta-Analysis
by: Jun Wang, et al.
Published: (2012-01-01)

Hypofractionated Stereotactic Radiotherapy after Transarterial Chemoembolisation Failure in an Unresectable Hepatocellular Carcinoma: A Case Presentation
by: Francesco Fiorica, et al.
Published: (2013-01-01)

TP53 Mutation Predicts Worse Survival and Earlier Local Progression in Patients with Hepatocellular Carcinoma Treated with Transarterial Embolization
by: Ken Zhao, et al.
Published: (2025-01-01)

Simultaneous Liver Venous Deprivation Following Hepatic Arterial Chemoembolization Before Major Hepatectomy for Hepatocellular Carcinoma: A New Methods to Achieve Hypertrophy Liver Remnant
by: Zhang S, et al.
Published: (2025-02-01)

Real-Life Report on Chemoembolization Using DEBIRI for Liver Metastases from Colorectal Cancer
by: M. Stutz, et al.
Published: (2015-01-01)

Prognostic impact of presenting symptoms of patients with hepatocellular carcinoma
by: Samuel Jun Ming Lim, et al.
Published: (2024-08-01)

Clinical Characteristics and Outcomes of Acute Lung Injury Caused by Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Retrospective Cohort Study from a Single Institution in China
by: Liang-jie Fang, et al.
Published: (2019-01-01)

Deciphering Platelet Kinetics in Diagnostic and Prognostic Evaluation of Hepatocellular Carcinoma
by: Bibek Aryal, et al.
Published: (2018-01-01)

Construction and Analysis of Hepatocellular Carcinoma Prognostic Model Based on Random Forest
by: Yikai Wang, et al.
Published: (2023-01-01)

The Prognostic Significance of TRs in Hepatocellular Carcinoma: Insights from TCGA and GEO Databases
by: Hao Zhou, et al.
Published: (2025-01-01)

NOL-7 serves as a potential prognostic-related biomarker for hepatocellular carcinoma
by: Qiucheng Lei, et al.
Published: (2025-01-01)

Comparison of Epirubicin-Iodized Oil Suspension and Emulsion for Transcatheter Arterial Chemoembolization in VX2 Tumor
by: Tatsuo Ueda, et al.
Published: (2012-01-01)

The Prognostic Value of Peripheral Blood Inflammatory Markers in Hepatocellular Carcinoma Treated with Lenvatinib Combined with PD-1 Inhibitors
by: Xin Y, et al.
Published: (2025-01-01)

Identification of Key Genes and Prognostic Value Analysis in Hepatocellular Carcinoma by Integrated Bioinformatics Analysis
by: Meng Wang, et al.
Published: (2019-01-01)

A prognostic model of 8-T/B cell receptor-related signatures for hepatocellular carcinoma
by: Xuan Zuo, et al.
Published: (2025-01-01)

The Features of Extrahepatic Collateral Arteries Related to Hepatic Artery Occlusion and Benefits in the Transarterial Management of Liver Tumors
by: Lin Yang, et al.
Published: (2013-01-01)

Prognostic significance of tumor angiogenesis markers in advanced cervical cancer undergoing chemotherapy
by: I Nyoman Bayu Mahendra, et al.
Published: (2024-12-01)

Intraoperative Electrical Nerve Stimulation as a Prognostic Tool in Patients Undergoing Peripheral Nerve Neurolysis
by: Christoph A. Schroen, BS, et al.
Published: (2025-01-01)

TMEM147 Correlates with Immune Infiltration and Serve as a Potential Prognostic Biomarker in Hepatocellular Carcinoma
by: Sheng Cheng, et al.
Published: (2023-01-01)

Prognostic and diagnostic significance of circRNAs expression in hepatocellular carcinoma patients: A meta‐analysis
by: Xin Huang, et al.
Published: (2019-03-01)

Clinical Outcome of Superselective Transarterial Embolization for Acute Colonic Gastrointestinal Bleeding: A Retrospective Single-Center Experience
by: Rajendra Kumar Behera, et al.

CDC25B Is a Prognostic Biomarker Associated With Immune Infiltration and Drug Sensitivity in Hepatocellular Carcinoma
by: Zixiang Huang, et al.
Published: (2024-01-01)

Extrapolating Prognostic Factors of Primary Curative Resection to Postresection Recurrences Hepatocellular Carcinoma Treatable by Radiofrequency Ablation
by: Hui Ma, et al.
Published: (2021-01-01)

Survival and Prognostic Factors in Patients with Hepatocellular Carcinoma Treated by Percutaneous Ethanol Injection: A 10-Year Experience
by: Roberto Mazzanti, et al.
Published: (2004-01-01)

Therapeutic efficacy and prognostic indicators in re-resection for recurrent hepatocellular carcinoma: Insights from a retrospective study
by: Qi Fan, MM, et al.
Published: (2025-01-01)